MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms (L39923) - R1 - Effective July 3, 2025

Date Posted: September 25, 25

This MolDX Local Coverage Determination (LCD) has been revised under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).

Effective Date: July 3, 2025

Summary of Changes:

Under Coverage Indications, Limitations and/or Medical Necessity updated paragraph 6, number 3. with symbol =.

Updated Related Local Coverage Documents added Billing and Coding: MolDX: BCR-ABL.

Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCD or access it via the CMS Medicare Coverage Database (MCD).

Last Updated Sep 24 , 2025